This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Almost Nine In Ten Doctors Believe That Government Should Introduce New Measures To Control Whiplash Claims [1]

COBHAM, England, September 20, 2012 /PRNewswire/ --

AXA, one of the UK's leading car insurers, has carried out research among UK doctors as part of its ongoing campaign to understand the culture of Personal Injury (PI) claims in the UK and reduce the payouts that have driven substantial rises in car insurance premiums.

The research revealed that doctors were under pressure to be part of the £2bn PI payout [2] not just through increasing numbers of whiplash patients taking up surgery time but with 7% actually being offered money to refer patients with whiplash injuries.

Over the last month, AXA car insurance polled doctors across the UK and an overwhelming 88% of those surveyed said they felt the government should introduce new measures to control whiplash claims for motorists.

22% said they had seen a substantial increase in whiplash patients over the last five years while a further 40% had seen a moderate increase in this period. Over the last year alone 11% had seen substantial increases and 31% moderate increases.  

Doctors surveyed believe that on average, 37% of patients who come to them with whiplash as a result of a car accident are fraudulent, while a third of doctors believe this number to be over 50%.

Over half (58%) of the doctors involved in the AXA study signed off 50 per cent or less of patients as having a genuine whiplash injury.

One of the biggest problems faced by doctors is the accuracy of whiplash diagnosis - only 7% believe it is very easy to accurately diagnose.

To improve this situation, 78% agree that there should be a more rigorous approach to assessing injuries, while access to more detailed guidelines around whiplash type injuries was desired by 71% of doctors surveyed. Better tests (47%), access to specialist clinics (38%) and expert opinion (39%) were also cited as popular improvements that could be made.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.31%
FB $102.01 0.10%
GOOG $682.40 -0.10%
TSLA $151.04 0.38%
YHOO $27.04 1.05%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs